Peritoneal albumin excretion is a strong predictor of cardiovascular events in peritoneal dialysis patients: A prospective cohort study

Peritoneal Dialysis International

Volumn 25, Issue 5, 2005, Pages 445-452

  Szeto, Cheuk Chun ^a   Chow, Kai Ming ^a   Lam, Christopher Wai Kei ^a   Cheung, Robert ^a   Kwan, Bonnie Ching Ha ^a   Chung, Kwok Yi ^a   Leung, Chi Bon ^a   Li, Philip Kam Tao ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Atherosclerosis; Cardiovascular disease event; Inflammation; Peritoneal albumin excretion

Indexed keywords

ALBUMIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEMODIALYSIS PATIENT; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LENGTH OF STAY; MALE; MORTALITY; PERITONEAL DIALYSIS; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANK SUM TEST; REGRESSION ANALYSIS; RISK ASSESSMENT; SURVIVAL TIME;

EID: 26844542962     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080502500508     Document Type: Article

References (40)

1. Maseri A. Inflammation, atherosclerosis, and ischemic events - exploring the hidden side of the moon. N Engl J Med 1997; 336:1014-16.
2. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55:1899-911.
3. Herzig KA, Purdie DM, Chang W, Brown AM, Hawley CM, Campbell SB, et al. Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients? J Am Soc Nephrol 2001; 12:814-21.
4. Yeun JY, Levine RA, Mantadilok V, Kaysen GA. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2000; 35:469-76.
5. Flores EA, Bistrian BR, Pomposelli JJ, Dinarello CA, Blackburn GL, Istfan NW. Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin 1. J Clin Invest 1989; 83:1614-22.
6. Bergstrom J, Wang T, Lindholm B. Factors contributing to catabolism in end-stage renal disease patients. Miner Electrolyte Metab 1998; 24:92-101.
7. Barton BE. IL-6-like cytokines and cancer cachexia: consequences of chronic inflammation. Immunol Res 2001; 23:41-58.
8. Kaysen GA, Stevenson FT, Depner TA. Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis 1997; 29:658-68.
9. Yeun JY, Kaysen GA. Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin in peritoneal dialysis patients. Am J Kidney Dis 1997; 30:923-7.
10. Stenvinkel P, Heimburger O, Lindholm B, Kaysen GA, Bergstrom J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 2000; 15:953-60.
11. Pecoits-Filho R, Stenvinkel P, Wang AY, Heimburger O, Lindholm B. Chronic inflammation in peritoneal dialysis: the search for the holy grail? Perit Dial Int 2004; 24: 327-39.
12. Anderson TJ, Gerhard MD, Meredith IT, Charbonneau F, Delagrange D, Creager MA, et al. Systemic nature of endothelial dysfunction in atherosclerosis. Am J Cardiol 1995; 75:71B-74B.
13. Otsuki M, Hashimoto K, Morimoto Y, Kishimoto T, Kasayama S. Circulating vascular cell adhesion molecule-1 (VCAM-1) in atherosclerotic NIDDM patients. Diabetes 1997; 46:2096-101.
14. Peter K, Weirich U, Nordt TK, Ruef J, Bode C. Soluble vascular cell adhesion molecule-1 (VCAM-1) as potential marker of atherosclerosis. Thromb Haemost 1999; 82(Suppl 1):38-43.
15. Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 2001; 107:1255-62.
16. Feldt-Rasmussen B. Microalbuminuria, endothelial dysfunction and cardiovascular risk. Diabetes Metab 2000; 26(Suppl 4):64-6.
17. Beilin J, Stanton KG, McCann VJ, Knuiman MW, Divitini ML. Microalbuminuria in type 2 diabetes: an independent predictor of cardiovascular mortality. Aust NZ J Med 1996; 26:519-25.
18. Agewall S, Wikstrand J, Ljungman S, Fagerberg B. Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group. Am J Cardiol 1997; 80:164-9.
19. Hillege HL, Janssen WM, Bak AA, Diercks GF, Grobbee DE, Crijns HJ, et al. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med 2001; 249:519-26.,
20. Adams MR, Kinlay S, Blake GJ, Orford JL, Ganz P, Selwyn AP. Atherogenic lipids and endothelial dysfunction: mechanisms in the genesis of ischemic syndromes. Annu Rev Med 2000; 51:149-67.
21. Szeto CC, Chow KM, Chung KY, Kwan BC, Li PK. Peritoneal protein and albumin excretion as markers of cardiovascular risk factor and systemic endothelial dysfunction. Hong Kong J Nephrol 2004; 6:31-7.
22. Twardowski ZJ, Nolph KD, Prowant B, Ryan L, Moore H, Nielsen MP. Peritoneal equilibration test. Perit Dial Bull 1987; 7:138-47.
23. Krediet RT, Boeschoten EW, Zuyderhoudt FMJ, Strackee J, Arisz L. Simple assessment of the efficacy of peritoneal transport in continuous ambulatory peritoneal dialysis patients. Blood Purif 1986; 4:194-203.
24. Noe DA. A body surface area nomogram based on the formula of Gehan and George. J Pharm Sci 1991; 80:501.
25. Mak TW, Cheung CK, Cheung CM, Leung CB, Lam CW, Lai KN. Interference of creatinine measurement in CAPD fluid was dependent on glucose and creatinine concentrations. Nephrol Dial Transplant 1997; 12:184-6.
26. Forbes GB, Bruining GJ. Urinary creatinine excretion and lean body mass. Am J Clin Nutr 1976; 29:1359-66.
27. The ROC's Handbook of Diet. 2nd ed. Taipei: Department of Health, Republic of China (Taiwan); 1994: 20-1.
28. Bergstrom J, Heimburger O, Lindholm B. Calculation of the protein equivalent of total nitrogen appearance from urea appearance. Which formulas should be used? Perit Dial Int 1998; 18:467-73.
29. Cox D. Regression models and life-tables. Journal of the Royal Statistical Society Series B 1972; 34:187-201.
30. Wang T, Heimburger O, Waniewski J, Bergstrom J, Lindholm B. Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients. Nephrol Dial Transplant 1998; 13:1242-9.
31. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D. Increased peritoneal transport is associated with decreased patient and technique survival for continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 1998; 9:1285-92.
32. Szeto CC, Law MC, Wong TY, Leung CB, Li PK. Peritoneal transport status correlates with morbidity but not longitudinal change of nutritional status of continuous ambulatory peritoneal dialysis patients - a two-year prospective study. Am J Kidney Dis 2001; 37:329-36.
33. Szeto CC, Wong TY, Lai KB, Lam CW, Lai KN, Li PK. Dialysate hyaluronan concentration predicts survival but not peritoneal sclerosis in continuous ambulatory peritoneal dialysis (CAPD). Am J Kidney Dis 2000; 36:609-14.
34. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 1996; 7:198-207.
35. Szeto CC, Wong TY, Leung CB, Wang AY, Law MC, Lui SF, et al. Importance of dialysis adequacy in mortality and morbidity of Chinese CAPD patients. Kidney Int 2000; 58: 400-7.
36. Wang AY, Woo J, Lam CW, Wang M, Sea MM, Lui SF, et al. Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients? J Am Soc Nephrol 2003; 14:1871-9.
37. Hutchesson A, Martin S. Influence of cholesterol on survival after stroke. Regression to the mean may have been a factor. BMJ 1997; 315:1158.
38. Appel LJ, Stason WB. Ambulatory blood pressure monitoring and blood pressure self-measurement in the diagnosis and management of hypertension. Ann Intern Med 1993; 118:867-82.
39. Lo WK, Brendolan A, Prowant BF, Moore HL, Khanna R, Twardowski ZJ, et al. Changes in the peritoneal equilibration test in selected chronic peritoneal dialysis patients. J Am Soc Nephrol 1994; 4:1466-74.
40. Raj DS, Langos V, Gangam N, Roscoe J. Ethnic variability in peritoneal equilibration test and urea kinetics. Am J Kidney Dis 1997; 30:374-81.